This page includes the latest FDA filings for Acura Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | OTHER OTC Market | ACUR | DUNS 001315530 |
Device Company | Device | Date |
|---|---|---|
| Acura Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Otc Medication | 2020-07-15 |
| Acura Pharmaceuticals, Inc. | Nexafed | 2020-07-10 |
| Acura Pharmaceuticals, Inc., Patheon Pharmaceuticals, Inc. | Otc Medication | 2012-12-10 |
| NCAGE Code | 6ZMA1 | ACURA PHARMACEUTICALS, INC. |
| CAGE Code | 6ZMA1 | ACURA PHARMACEUTICALS, INC. |
| S.A.M. Registration | 6ZMA1 [1315530] | ACURA PHARMACEUTICALS, INC. |
| SEC | 0000786947 | ACURA PHARMACEUTICALS, INC of NEW YORK |